Is Viking Therapeutics a Millionaire-Maker? [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
Ideally, the company would have a pipeline featuring multiple promising candidates with significant commercial potential. Viking Therapeutics (NASDAQ: VKTX) fits the profile of such a stock to a T. Could Viking be a millionaire-maker? What's in Viking Therapeutics' quiver Many small biopharmaceutical companies are essentially one-trick ponies. They're betting the farm on a single pipeline candidate. Not Viking Therapeutics. The company is evaluating lead candidate VK2809 in a phase 2 study for treating non-alcoholic steatohepatitis (NASH), which is also called metabolic-associated steatohepatitis (MASH). Viking reported in the first quarter of 2024 that VK2809 achieved the study's primary endpoint of statistically significant reductions in liver fat after 12 weeks of treatment. In June, it announced further results showing that the experimental drug achieved NASH resolution with no worsening of fibrosis in up to 75% of patients, along with other positive results. Another pip
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Viking Therapeutics, Inc. (VKTX) Sees a More Significant Dip Than Broader Market: Some Facts to Know [Yahoo! Finance]Yahoo! Finance
- Several Factors Negatively Impacted Viking Therapeutics (VKTX) in Q2 [Yahoo! Finance]Yahoo! Finance
- Viking Surges 342% in the Past Year: How Should You Play the Stock? [Yahoo! Finance]Yahoo! Finance
- The Best Biotech Stock to Invest $1,000 in Right Now [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics: GLP-1/GIP Receptor Agonist And Its Competitive Landscape [Seeking Alpha]Seeking Alpha
VKTX
Earnings
- 7/24/24 - Beat
VKTX
Sec Filings
- 8/22/24 - Form 4
- 8/22/24 - Form 4
- 8/21/24 - Form 144
- VKTX's page on the SEC website